<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">hepatitis </span>
   <span class="font21">HBV </span>
   <span class="font21">chronic </span>
   <span class="font20">treatment </span>
   <span class="font20">viral </span>
   <span class="font20">HCV </span>
   <span class="font20">virus </span>
   <span class="font19">patients </span>
   <span class="font17">cirrhosis </span>
   <span class="font17">liver </span>
   <span class="font16">infection </span>
   <span class="font15">disease </span>
   <span class="font15">antiviral </span>
   <span class="font15">DNA </span>
   <span class="font14">{border-style </span>
   <span class="font14">United </span>
   <span class="font14">px;} </span>
   <span class="font14">risk </span>
   <span class="font14">screening </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">Hepatitis </span>
   <span class="font13">prevalence </span>
   <span class="font13">associated </span>
   <span class="font13">decompensated </span>
   <span class="font13">including </span>
   <span class="font13">renal </span>
   <span class="font13">care </span>
   <span class="font13">collab: </span>
   <span class="font13">recent </span>
   <span class="font13">therapies </span>
   <span class="font12">ALT </span>
   <span class="font12">burden </span>
   <span class="font12">management </span>
   <span class="font12">population </span>
   <span class="font12">recommendations </span>
   <span class="font12">Hepatology;:�?. </span>
   <span class="font12">drug </span>
   <span class="font12">virologic </span>
   <span class="font12">&amp;gt; </span>
   <span class="font12">HDV </span>
   <span class="font12">Health </span>
   <span class="font12">Hepatol;:�?. </span>
   <span class="font12">TAF </span>
   <span class="font12">World </span>
   <span class="font12">cure </span>
   <span class="font12">infection, </span>
   <span class="font12">infection. </span>
   <span class="font12">patient </span>
   <span class="font12">populations </span>
   <span class="font12">transplant </span>
   <span class="font12">with/without </span>
   <span class="font12">years </span>
   <span class="font12">Additionally, </span>
   <span class="font12">Chronic </span>
   <span class="font12">DAA </span>
   <span class="font12">HBsAg </span>
   <span class="font12">However, </span>
   <span class="font12">Liver </span>
   <span class="font12">TDF </span>
   <span class="font12">Treatment </span>
   <span class="font12">development </span>
   <span class="font12">strategies </span>
   <span class="font12">tenofovir </span>
   <span class="font12">testing </span>
   <span class="font12">therapy </span>
   <span class="font12">use </span>
   <span class="font12">weeks </span>
   <span class="font12">AASLD </span>
   <span class="font12">cccDNA </span>
   <span class="font12">current </span>
   <span class="font12">effective </span>
   <span class="font12">future </span>
   <span class="font12">infected </span>
   <span class="font12">needed </span>
   <span class="font12">new </span>
   <span class="font12">rates </span>
   <span class="font12">replication </span>
   <span class="font11">SVR </span>
   <span class="font11">States, </span>
   <span class="font11">Study </span>
   <span class="font11">antigen </span>
   <span class="font11">bone </span>
   <span class="font11">direct�?acting </span>
   <span class="font11">high </span>
   <span class="font11">normal </span>
   <span class="font11">px; </span>
   <span class="font11">review </span>
   <span class="font11">study </span>
   <span class="font11">treating </span>
   <span class="font11">work </span>
   <span class="font11">{font-family </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">Association </span>
   <span class="font11">Disease </span>
   <span class="font11">EASL </span>
   <span class="font11">Gastroenterol </span>
   <span class="font11">Global </span>
   <span class="font11">IU/mL </span>
   <span class="font11">RNA </span>
   <span class="font11">States. </span>
   <span class="font11">U.S. </span>
   <span class="font11">Viral </span>
   <span class="font11">access </span>
   <span class="font11">clinical </span>
   <span class="font11">estimated </span>
   <span class="font11">following </span>
   <span class="font11">font-size </span>
   <span class="font11">health </span>
   <span class="font11">hepatitis, </span>
   <span class="font11">inhibitors </span>
   <span class="font11">months </span>
   <span class="font11">need </span>
   <span class="font11">regarding </span>
   <span class="font11">regardless </span>
   <span class="font11">reported </span>
   <span class="font11">systematic </span>
   <span class="font11">targeting </span>
   <span class="font11">transplantation </span>
   <span class="font11">treated </span>
   <span class="font11">treatment. </span>
   <span class="font11">Clin </span>
   <span class="font11">Following </span>
   <span class="font11">Future </span>
   <span class="font11">HBeAg�?positive </span>
   <span class="font11">HCV�?infected </span>
   <span class="font11">Med;:�?. </span>
   <span class="font11">Organization </span>
   <span class="font11">Screening </span>
   <span class="font11">Wiley </span>
   <span class="font11">compared </span>
   <span class="font11">cure. </span>
   <span class="font11">currently </span>
   <span class="font11">double; </span>
   <span class="font11">drugs </span>
   <span class="font11">duration </span>
   <span class="font11">entry </span>
   <span class="font11">failure </span>
   <span class="font11">fibrosis </span>
   <span class="font11">hepatocellular </span>
   <span class="font11">history </span>
   <span class="font11">identify </span>
   <span class="font11">include </span>
   <span class="font11">individuals </span>
   <span class="font11">multiple </span>
   <span class="font11">past </span>
   <span class="font11">patients. </span>
   <span class="font11">phase </span>
   <span class="font11">prior </span>
   <span class="font11">recommended </span>
   <span class="font11">treat </span>
   <span class="font11">treatment, </span>
   <span class="font11">vaccination </span>
   <span class="font11">vaccine </span>
   <span class="font11">%�?% </span>
   <span class="font11">(&amp;gt;%), </span>
   <span class="font11">(C) </span>
   <span class="font11">(Table </span>
   <span class="font11">Abbreviations: </span>
   <span class="font11">European </span>
   <span class="font11">Guidance </span>
   <span class="font11">John </span>
   <span class="font11">Ltd, </span>
   <span class="font11">Preventive </span>
   <span class="font11">Services </span>
   <span class="font11">Sons, </span>
   <span class="font11">Table </span>
   <span class="font11">Virus </span>
   <span class="font11">acute </span>
   <span class="font11">adults </span>
   <span class="font11">advanced </span>
   <span class="font11">advances </span>
   <span class="font11">allow </span>
   <span class="font11">bold </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">disease, </span>
   <span class="font11">disoproxil </span>
   <span class="font11">distribution </span>
   <span class="font11">endpoints </span>
   <span class="font11">epidemiology </span>
   <span class="font11">experienced </span>
   <span class="font11">function </span>
   <span class="font11">genotype </span>
   <span class="font11">hepatocyte </span>
   <span class="font11">hold </span>
   <span class="font11">increase </span>
   <span class="font11">infection: </span>
   <span class="font11">key </span>
   <span class="font11">lower </span>
   <span class="font11">organ </span>
   <span class="font11">patients, </span>
   <span class="font11">pegylated </span>
   <span class="font11">people </span>
   <span class="font11">potential </span>
   <span class="font11">previous </span>
   <span class="font11">remains </span>
   <span class="font11">research </span>
   <span class="font11">response </span>
   <span class="font11">safety </span>
   <span class="font11">seen </span>
   <span class="font11">sofosbuvir </span>
   <span class="font11">solid; </span>
   <span class="font11">testing, </span>
   <span class="font11">therapies. </span>
   <span class="font11">therapy, </span>
   <span class="font11">therapy. </span>
   <span class="font11">treatments </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">−.% </span>
   <span class="font11">�?week </span>
   <span class="font10">AASLD�?IDSA </span>
   <span class="font10">Add </span>
   <span class="font10">ETV </span>
   <span class="font10">Force </span>
   <span class="font10">Guidelines </span>
   <span class="font10">HBeAg�?negative </span>
   <span class="font10">HCV, </span>
   <span class="font10">HIV </span>
   <span class="font10">Infect </span>
   <span class="font10">Infection </span>
   <span class="font10">RBV </span>
   <span class="font10">Recommendations </span>
   <span class="font10">States </span>
   <span class="font10">TDF, </span>
   <span class="font10">Task </span>
   <span class="font10">ULN </span>
   <span class="font10">aged </span>
   <span class="font10">analysis </span>
   <span class="font10">antibody </span>
   <span class="font10">anticipated </span>
   <span class="font10">approved </span>
   <span class="font10">birth </span>
   <span class="font10">carcinoma </span>
   <span class="font10">care, </span>
   <span class="font10">cases </span>
   <span class="font10">chronically </span>
   <span class="font10">cirrhosis, </span>
   <span class="font10">closed </span>
   <span class="font10">cohort </span>
   <span class="font10">coinfection </span>
   <span class="font10">cost�?effective </span>
   <span class="font10">courier; </span>
   <span class="font10">covalently </span>
   <span class="font10">data </span>
   <span class="font10">detectable </span>
   <span class="font10">directions </span>
   <span class="font10">efficacy </span>
   <span class="font10">elevated </span>
   <span class="font10">elimination </span>
   <span class="font10">em; </span>
   <span class="font10">fumarate </span>
   <span class="font10">generally </span>
   <span class="font10">genotypes </span>
   <span class="font10">guidance </span>
   <span class="font10">human </span>
   <span class="font10">identifying </span>
   <span class="font10">immunodeficiency </span>
   <span class="font10">important </span>
   <span class="font10">inhibitor </span>
   <span class="font10">inject </span>
   <span class="font10">large </span>
   <span class="font10">life </span>
   <span class="font10">million </span>
   <span class="font10">nucleos(t)ide </span>
   <span class="font10">optimal </span>
   <span class="font10">oral </span>
   <span class="font10">persistent </span>
   <span class="font10">pgRNA </span>
   <span class="font10">providers. </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">receiving </span>
   <span class="font10">reduced </span>
   <span class="font10">regimen </span>
   <span class="font10">resistance </span>
   <span class="font10">result </span>
   <span class="font10">screen </span>
   <span class="font10">screening, </span>
   <span class="font10">surface </span>
   <span class="font10">surveillance </span>
   <span class="font10">targets </span>
   <span class="font10">trials </span>
   <span class="font10">vs. </span>
   <span class="font10">worldwide </span>
   <span class="font10">years, </span>
  </p>
 </body>
</html>
